START CENTER FOR CANCER CARE THE CURE STARTS HERE
Live / Registered — Registered (as of 19 Sept 2023)
What this means for you
Registered since 19 Sept 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97468939
- Registration number
- 7167596
- Mark type
- Design + words
- Filed
- 21 Jun 2022
- Published for opposition
- 04 Jul 2023
- Registered
- 19 Sept 2023
Goods and services
- Class 042 — Scientific and technological services: Medical and scientific research, namely, conducting clinical trials for others; Medical and scientific research services in the field of cancer diagnosis, therapy, prevention, and treatment, and conducting clinical trials for others in the field of cancer diagnosis, therapy, prevention, and treatment; Pharmaceutical drug development services; Structural and functional analysis of genomes
- Class 044 — Medical, beauty and agricultural services: Medical services, namely, cancer diagnosis, therapy, prevention, and treatment; Providing healthcare information in the field of cancer prevention, screening, diagnosis and treatment
Owner
- South Texas Accelerated Research Therapeutics, LLC, Houston, TX, US
- South Texas Accelerated Research Therapeutics, LLC, Houston, TX, US
- South Texas Accelerated Research Therapeutics, LLC, Houston, TX, US
Prior registrations
Prosecution history
- 19 Feb 2026 — WITHDRAWAL OF ATTORNEY GRANTED
- 19 Feb 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED
- 19 Sept 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 19 Sept 2023 — REGISTERED-PRINCIPAL REGISTER
- 04 Jul 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 04 Jul 2023 — PUBLISHED FOR OPPOSITION
- 14 Jun 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 May 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 May 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 01 May 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 01 May 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 31 Mar 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 Mar 2023 — NON-FINAL ACTION E-MAILED
- 31 Mar 2023 — NON-FINAL ACTION WRITTEN
- 31 Mar 2023 — ASSIGNED TO EXAMINER